| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.05 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.08 | 0.07 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.07 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.07 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.08 | 0.08 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.097 | 0.08 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.089 | 0.08 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.089 | 0.08 |